- Home
- CARM vs EVGN Comparison
CARM vs EVGN Comparison
Compare CARM & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- EVGN
- Stock Information
- Founded
- CARM 2016
- EVGN 1999
- Country
- CARM United States
- EVGN Israel
- Employees
- CARM N/A
- EVGN N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- CARM Health Care
- EVGN Industrials
- Exchange
- CARM Nasdaq
- EVGN Nasdaq
- Market Cap
- CARM 12.2M
- EVGN 11.6M
- IPO Year
- CARM N/A
- EVGN N/A
- Fundamental
- Price
- CARM $0.37
- EVGN $1.27
- Analyst Decision
- CARM Hold
- EVGN Strong Buy
- Analyst Count
- CARM 5
- EVGN 1
- Target Price
- CARM $0.90
- EVGN $3.50
- AVG Volume (30 Days)
- CARM 25.7M
- EVGN 46.1K
- Earning Date
- CARM 11-06-2025
- EVGN 08-19-2025
- Dividend Yield
- CARM N/A
- EVGN N/A
- EPS Growth
- CARM N/A
- EVGN N/A
- EPS
- CARM N/A
- EVGN N/A
- Revenue
- CARM $10,767,000.00
- EVGN $9,444,000.00
- Revenue This Year
- CARM N/A
- EVGN N/A
- Revenue Next Year
- CARM N/A
- EVGN $63.64
- P/E Ratio
- CARM N/A
- EVGN N/A
- Revenue Growth
- CARM N/A
- EVGN N/A
- 52 Week Low
- CARM $0.14
- EVGN $0.95
- 52 Week High
- CARM $1.27
- EVGN $3.32
- Technical
- Relative Strength Index (RSI)
- CARM 55.76
- EVGN 50.50
- Support Level
- CARM $0.34
- EVGN $1.21
- Resistance Level
- CARM $0.44
- EVGN $1.31
- Average True Range (ATR)
- CARM 0.05
- EVGN 0.06
- MACD
- CARM 0.01
- EVGN 0.00
- Stochastic Oscillator
- CARM 47.28
- EVGN 64.71
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.